Matthew Callahan

Matthew Callahan

Founder chez BOTANIX PHARMACEUTICALS LIMITED

Fortune : 1 M $ au 31/03/2024

51 ans
Health Technology
Finance
Commercial Services

Profil

Matthew Callahan is the founder of iCeutica, Inc. (founded in 2005) and Stone Ridge Ventures Pty Ltd.
(founded in 2005).
He is currently the Chief Executive Officer at Churchill Pharmaceuticals and a Director at Riverside Partners LLC (New York) since 2021.
He is also a Non-Executive Director at Intellection Pty Ltd., a Director at Ben Franklin Technology Partners of Southeastern Pennsylvania since 2016, an Executive Director at Botanix Pharmaceuticals, Inc., a Non-Executive Director at Nemgenix Pty Ltd., a Non-Executive Director at Matteo Mining Corp.
Pty Ltd., a Director at Glycan Bioscience LLC, a Director at Thylacine Consulting LLC, an Executive Director at Respirion Pharmaceuticals Pty Ltd., and a Director at Microsize, Inc. Mr. Callahan's former positions include being the Chief Executive Officer at Dimerix Bioscience Pty Ltd.
from 2003 to 2005, a Director at The Cash Store Australia Holdings, Inc. in 2009, a Director at Glycan Biosciences, Inc. from 2006 to 2011, a Non-Executive Director at Orthocell Ltd.
from 2006 to 2019, a Non-Executive Director at Orthocell Ltd.
from 2020 to 2023, a Non-Executive Director at Emyria Ltd.
from 2018 to 2023, a General Manager at Xelor Software, Inc., and a General Manager & General Counsel at Nearmap Pty Ltd.
Mr. Callahan's education includes an undergraduate degree and an MBA from The University of Western Australia.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/10/2023 19 655 556 ( 5,36% ) 756 542 $ 31/03/2024
15/01/2024 1 229 622 ( 0,59% ) 312 865 $ 31/03/2024

Postes actifs de Matthew Callahan

SociétésPosteDébut
BOTANIX PHARMACEUTICALS LIMITED Founder 10/02/2020
Director/Board Member -
Founder 01/01/2005
Private Equity Investor 01/09/2021
Director/Board Member -
Thylacine Consulting LLC Director/Board Member -
Churchill Pharmaceuticals Chief Executive Officer -
Director/Board Member -
Director/Board Member -
░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Matthew Callahan

Anciens postes connus de Matthew Callahan

SociétésPosteFin
░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Matthew Callahan

Formation de Matthew Callahan

The University of Western Australia Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Matthew Callahan

Relations

100 +

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
BOTANIX PHARMACEUTICALS LIMITED

Health Technology

EMYRIA LIMITED

Technology Services

Entreprise privées19

Health Technology

Technology Services

Industrial Services

Finance

Non-Energy Minerals

Miscellaneous

Finance

Finance

Glycan Biosciences, Inc.

Orthocell Ltd.

Distribution Services

Health Technology

Commercial Services

Non-Energy Minerals

Health Technology

Churchill Pharmaceuticals

Thylacine Consulting LLC

Commercial Services

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Matthew Callahan